a Jasko FT/IR-6100 type A spectrophotometer (Tokyo, Japan). Mass spectra were obtained on a mass spectrometer model SSQ 7000 produced by Finnigan (San Jose, CA, USA) and operated at 70 eV, and on a JEOL JMS 500 spectrometer (Tokyo, Japan) operated at 70 eV.
1 H and 13 C NMR spectra were obtained using a JEOL instrument at 500 and 125 MHz, respectively. Chemical shifts are given in ppm with tetramethylsilane (TMS) as internal standard using CDCl 3 and CD 3 OD as solvents.
Column chromatography (CC) was carried out using silica gel (60 to 230 mesh; Fluka, Buchs, Switzerland). Thin-layer chromatography (TLC) was performed on silica gel-coated aluminum plates (silica gel 60 GF 254 ; Fluka). Developed chromatograms were visualized by spraying with anisaldehyde/sulfuric acid reagent followed by heating at 100 °C for 10 min or under UV light. The solvents used for extraction, separation, and/ or detection were of analytical grade.
Materials for biological activity study
CCl 4 , paraffi n oil, 1% acetic acid, sulforhodamine B (SRB) protein dye, 40% trichloroacetic acid (TCA) stock solution, 10 mM Tris-EDTA buffer (pH 10.5), gum acacia, silymarin, glibenclamide, streptozocin, RPMI medium, fetal bovine serum (FBS), L-glutamine, penicillin G sodium, streptomycin sulfate, trypsin, EDTA, dimethyl sulfoxide (DMSO), 2,2-diphenyl-1-picryl hydrazyl (DPPH), ascorbic acid, methanol, nutrient agar media, Sabouraud's agar media, cefotaxin, and nystatin were from Sigma/Aldrich (St. Louis, MO, USA). Glucomen-glyco ® blood glucose meter was from Menarini Biotech (Rome, Italy). The human breast adenocarcinoma cell line (MCF-7) was obtained from the Serum and Vaccine Research Institute, Giza, Egypt.
Animals
All animal care and experimental procedures were conducted in accordance with the guidelines of the animal ethics committee of the Faculty of Pharmacy, Zagazig University, Zagazig, Egypt (approval number P1-5, 24 May 2010) and were handled following the International Animal Ethics Committee Guidelines, ensuring minimum animal suffering. The Faculty of Medicine, Cairo University, Cairo, Egypt provided the experimental animals. All animals were held under standard laboratory conditions in the animal house of the Faculty of Medicine, Cairo University at 27 °C with a 12-h/12-h light/dark cycle. They were fed laboratory diet and water ad libitum. Adult male albino rats, weighing 150 -180 g, were used in hepatoprotective and hypoglycemic studies.
Statistical analysis
Signifi cance of the hepatoprotective and hypoglycemic effects of the plant extract were calculated using Student's t-test at P < 0.05.
Extraction and isolation of compounds
The air-dried whole powdered plants of G. parvifl ora (4 kg) were exhaustively extracted with 80% aqueous ethanol (3 x 10 L). The ethanolic extract was fi ltered and then concentrated under vacuum to yield 400 g of a viscous greenish residue. The residue was suspended in water and partitioned between light petroleum (b.p. 60 -80 °C, 5 x 0.5 L), chloroform (5 x 0.5 L), and ethyl acetate (5 x 0.5 L), successively. The organic solvents were evaporated under vacuum to yield 105, 2.9, and 6.5 g of fi nal residues, respectively.
Isolation of seven compounds from the light petroleum fraction
The light petroleum fraction (50 g) was redissolved in dichloromethane (75 mL), and the resulting solution was mixed with silica gel (35 g). The dry mixed initial zone was chromatographed on a silica gel column (100 cm x 5 cm, 450 g) at room temperature. The column was eluted with a gradient of a mixture of light petroleum/dichloromethane/methanol as mobile phase to afford seven compounds.
Isolation of four compounds from the ethyl acetate fraction
A dry mixed initial zone was obtained by dissolving 6 g of the ethyl acetate fraction in methanol (10 mL) mixed with 3 g silica gel. The dry zone was chromatographed on a silica gel column (75 cm x 3.5 cm, 240 g). The column was eluted with a gradient of a mixture of benzene/ethyl acetate as mobile phase to give four compounds.
Preparation and analysis of the essential oil
Fresh aerial parts of G. parvifl ora were subjected to hydrodistillation for 4 h using a Clev-enger-type apparatus. The yield was 0.1% (v/w) of a yellow coloured oil. The oil was analysed by gas chromatography/mass spectrometry (GC/MS) using a Clarus 600 gas chromatograph (Shelton, CO, USA) equipped with a fused silica column Rtx ® -5MS (equivalent to DB5; 30 m x 0.23 mm ID, 0.25 μm fi lm thickness). The capillary column was directly coupled to a quadruple mass spectrometer Clarus 600 T. EI-mass spectra were recorded at 70 eV.
The conditions were as follows: injector tempera ture, 150 °C; oven temperature program: initial temperature, 45 °C, 2 min isothermal, 45 -300 °C at 4 °C/min, 20 min isothermal; split ratio, 1:20; carrier gas, He (1.2 mL/min). Retention indices (RI) were calculated with respect to a set of co-injected standard n-alkanes.
Biological evaluation

Hepatoprotective effect
Twenty four male rats weighing 150 -180 g were used in this study. Elevated liver enzyme levels were induced by subcutaneous (s.c.) injection of 0.2 mL/100 g body weight (BW) of 40 mL/L CCl 4 dissolved in paraffi n oil. The injection was given twice a week for 6 weeks (Zhao et al., 2005) . The rats were divided into 4 groups (n = 6). Group I received liquid paraffi n oil only (normal control group), while the other groups (II-IV) received CCl 4 . Thereafter, group I received the vehicle (10% gum acacia), while group II (negative control) were cirrhotic rats that received the vehicle. Group III (positive control) were cirrhotic rats treated with the standard silymarin suspended in vehicle in a dose of 150 mg/kg BW, and group IV (intoxicated) were cirrhotic rats treated with the total ethanolic extract of G. parvifl ora in a dose of 400 mg/kg BW. The treatment period continued for 7 d. Blood samples were collected from the orbital sinus of fasted (for at least 8 h) rats. Serum was separated by centrifugation at 1370 x g for 15 min to determine the biological parameters. Liver enzymes, alanine aminotransferase (ALT) and proteins (albumin), were measured in the collected plasma.
Hypoglycemic effect
Twenty four adult male rats (150 -180 g) were used in this study. Diabetes was induced in rats by intraperitoneal (i.p.) injection of streptozocin (STZ) in a single dose of 75 mg/kg BW according to the method described by Sokeng et al. (2005) . Rats became diabetic after 5 d of injecting STZ, their blood glucose levels ranging from 250 to 288 mg/100 mL. Rats were divided into four groups (n = 6). The fi rst group was the nondiabetic group and received gum acacia mucilage (10%), it served as a control; the second was the diabetic group and received only the vehicle (10% gum acacia); the third and fourth diabetic groups received orally by gavage glibenclamide (5 mg/kg BW) and the total ethanolic extract of G. parvifl ora (400 mg/kg BW), respectively. Blood glucose levels were determined using a glucomenglyco ® blood glucose meter, 24 sensor strips.
Cytotoxic activity Cytotoxicity of the ethanolic extract was measured against MCF-7 cells using the SRB assay reported by Skehan et al. (1990) . Cells were seeded in a 96-well plate in fresh medium and left for 24 h at 37 °C under 5% CO 2 atmosphere, to attach to the wall of the plate. Thereafter cells were incubated with appropriate concentrations of the test extract (0.1, 1, 10, 100, 1000 μg/mL). The volumes were completed to 200 μL/well using fresh medium, and incubation was continued for 72 h. Control cells were treated with vehicle alone. The absorbance of each well was measured at 564 nm using an ELISA reader. Cell survival was measured as the percentage absorbance compared to the control (non-treated cells). The experiment was triplicated.
Antioxidant activity
The scavenging activity of the DPPH radicals was investigated according to the method of Peiwu et al. (1999) . Stock solutions of the crude ethanol extract and fractions (light petroleum, ethyl acetate) were prepared by dissolving 150 mg each in 1 mL of methanol. Methanolic DPPH solution (2.95 mL, 4.5 mg/100 mL) was added to 50 μL of test material in a disposable cuvette. The absorbance was measured at 517 nm at regular intervals of 15 s for 5 min. Ascorbic acid (at 0.1 M) was used as a standard as described by Govindarajan et al. (2003) .
The difference in the absorbance between the test sample and blank was expressed as percent inhibition taken as the activity: inhibition (%) = [(A B -A A )/A B ] · 100, where A B is the absorbance of the blank sample and A A is the absorbance of the tested extracts.
Antimicrobial activity
The cup-plate method (Woods and Washington, 1995) was used to detect the preliminary antimicrobial activity of the total ethanolic extract and of different fractions (light petroleum and ethyl acetate) of G. parvifl ora. The samples were dissolved in dimethyl formamide (DMF) at a concentration of 100 mg/mL. The nutrient agar or Sabouraud's agar (40 g/L dextrose, 10 g/L peptone, 20 g/L agar) were seeded at about 10 6 microbial cells. Each cup was fi lled with about 100 μL from each extract. Cefotaxin and nystatin (5 mg/mL) were used as standard antibacterial and antifungal, respectively. The plates were incubated overnight at 37 °C for bacteria and 30 °C for fungi. Zones of inhibition were measured (in mm).
Results and Discussion
Identifi cation of compounds
Silica gel column chromatography of the light petroleum fraction of G. parvifl ora resulted in the isolation of seven compounds including: triacontanol (Galala, 2009) , phytol (Kim et al., 2005) , β-sitosterol, stigmasterol (Goad and Akihisa, 1997), 7-hydroxy-β-sitosterol, 7-hydroxystigmasterol (McCarthy et al., 2005; Qiang et al., 2011) , and β-sitosterol-3-O-β-D-glucoside (Bayoumi et al., 2010) . The yields were 20, 1000, 550, 100, 5, 5, and 35 mg, respectively. Furthermore, column chromatography of the ethyl acetate fraction afforded four compounds including 3,4-dimethoxycinnamic acid (Torres et al., 2003; Nawwar et al., 2009) , protocatechuic acid (Yu et al., 2006) , fumaric acid (He et al., 2011; Zhang et al., 2010) , and uracil (Srivastava and Gupta, 2010) . The yields were 5, 30, 15, and 6 mg, respectively. Compounds were identifi ed from their spectral data (IR, MS, 1 H and/or 13 C NMR), physical properties, and comparison with the data reported in the literature.
Except β-sitosterol, stigmasterol, β-sitosterol-3-O-β-D-glucoside, and protocatechuic acid, all other compounds are reported for the fi rst time from this plant and the genus Galinsoga.
This result differs from those reported elsewhere in the literature. In contrast to previous reports (Pan et al., 2007; Tariq et al., 2008; Ferheen et al., 2009; Afza et al., 2012) , we obtained no evidence for α-spinasterol, diterpenes with a kaurene skeleton, 4-hydroxybenzoic acid, gallic acid, galinsoside A, galinsoside B, 7,3′,4′-trihydroxyfl avanone, and galinosoates.
Essential oil constituents
Altogether 48 identifi ed compounds covered 83.13% of all peaks observable in the chromatogram of the hydrodistilled oil of G. parvifl ora (Table I ) with (Z)-γ-bisabolene being the most abundant component (45.66%), followed by (E)-caryophyllene (4.99%), (Z)-bisabolol-11-ol (4.95%), and phytol (4.39%). Identifi cation of the compounds was based on their mass spectra, retention indices, and comparison with published data (Adams, 2007; El-Shazly and Hussein, 2004; El-Shazly et al., 2002 . On the other hand, we could not fi nd any traces of (Z)-3-hexen-1-ol, β-caryophyllene, and 6-demethoxy-ageratochrome which have been reported as major compounds in the essential oil of leaves from G. parvifl ora growing in Colombia (Pino et al., 2010) .
This divergence in the chemical profi le of G. parvifl ora may be attributed to either geographical and ecological factors, or be an indication of the existence of different chemotypes of this plant.
Biological evaluation
Hepatoprotective effect
As shown in Table II , the total ethanolic extract of G. parvifl ora (400 mg/kg BW) and the standard silymarin (150 mg/kg BW) signifi cantly reduced the level of ALT activity compared to the CCl 4 -treated group. The effect of the total ethanolic extract (400 mg/kg BW) was equivalent to 87% and 83% of ALT and total albumin, respectively, provoked by the standard silymarin (150 mg/kg BW).
Hypoglycemic effect
As shown in Table III , the potency of the total ethanolic extract of G. parvifl ora at a content of 400 mg/kg BW was nearly equivalent to that of glibenclamide (5 mg/kg BW) in reducing the blood glucose levels of diabetic rats.
Cytotoxic activity
The total ethanolic extract of G. parvifl ora at concentrations of 0.1, 1, 10, and 100 μg/mL exerted only a weak cytotoxic activity against the MCF-7 cell line. The percentage cell viabilities were 99.23, 98.21, 92.58, and 91.53, respectively. However, the extract in high concentration (1000 μg/mL) killed all cells. So, the extract was considered to be cytocidal rather than cytotoxic (Houghton et al., 2007) .
Antioxidant activity
In comparison with the standard 0.1 M ascorbic acid, the ethyl acetate fraction of G. parvifl ora exhibited strong antioxidant activity at a concentration of 150 mg/mL, the ethanolic extract showed moderate antioxidant activity at a concentration of 150 mg/mL, while the light petro leum fraction showed weak antioxidant activity at the same concentration. Our results are in agreement with those reported for G. parvifl ora from Chile ( Ranilla et al., 2010) and Poland (Bazylko et al., 2012) .
Antimicrobial activity
All extracts had a weak antibacterial effect against all tested Gram-positive bacteria, except B. subtilis (Table IV) . For the tested Gram-negative bacteria, all extracts exhibited a weak antibacterial effect against K. pneumoniae and S. typhimurium, and a signifi cant effect against E. coli and P. aeruginosa, relative to the standard cefotaxin. The extracts were strongly antifungal against A. niger and C. albicans, relative to the standard nystatin.
The presence of 3,4-dimethoxycinnamic acid, protocatechuic acid, and fumaric acid, as well as the high content of phytol and sterols as constituents of G. parvifl ora may contribute to the appreciable hepatoprotective, hypoglycemic, antioxidant, and antimicrobial effects (Fred-Jaiyesimi et al., 2009; He et al., 2011; Nagavamsikrishna et al., 2012; Ranilla et al., 2010; Radhiga and Pugalendi, 2011; Harini and Pugalendi, 2010) . In addition to our phytochemical and biological studies of G. parvifl ora, close monitoring of hepatic and renal safety variables as well as rigorous long-term clinical follow-up studies are required before extracts from this plant can be used as a natural therapy.
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